Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | H-Pro-His-Cys-Lys-Arg-Met-OH;159147-88-3;Antioxidant peptide A;(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2R)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2S)-pyrrolidine-2-carbonyl]amino]propanoyl]amino]-3-sulfanylpropanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylsulfanylbutanoic acid;L-Methionine, L-prolyl-L-histidyl-L-cysteinyl-L-lysyl-L-arginyl-;SCHEMBL16520819;DTXSID30655320;HY-P1512;FP108675;H-Pro-His-Cys-Lys-Arg-Met-OH TFA salt;CS-0044610;L-Prolyl-L-histidyl-L-cysteinyl-L-lysyl-N~5~-(diaminomethylidene)-L-ornithyl-L-methionine; |
M.F/Formula | C31H54N12O7S2 |
M.W/Mr. | 771 |
Sequence | One Letter Code:PHCKRM Three Letter Code:H-Pro-His-Cys-Lys-Arg-Met-OH |
Areas of Interest | Cancer Research |
InChI | InChI=1S/C31H54N12O7S2/c1-52-13-9-22(30(49)50)41-27(46)21(8-5-12-37-31(33)34)39-26(45)20(6-2-3-10-32)40-29(48)24(16-51)43-28(47)23(14-18-15-35-17-38-18)42-25(44)19-7-4-11-36-19/h15,17,19-24,36,51H,2-14,16,32H2,1H3,(H,35,38)(H,39,45)(H,40,48)(H,41,46)(H,42,44)(H,43,47)(H,49,50)(H4,33,34,37)/t19-,20-,21-,22-,23-,24-/m0/s1 |
InChI Key | NHZJOSHEZUEDBO-BTNSXGMBSA-N |
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.